Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present That Marketing Solution, Inc. (OTC: TSTS).

Full DD Report for TSTS

You must become a subscriber to view this report.



Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-11N/A0.0001N/AN/A0
2018-12-100.00010.00010.00010.00019,150,000
2018-12-070.00020.00010.00020.000131,662,402
2018-12-060.00010.00020.00020.000119,470,000
2018-12-050.000150.0000010.000150.0000011,370,999

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-10250,0009,150,0002.7322Cover
2018-12-0720,300,00022,560,00089.9823Short
2018-12-065,760,00019,470,00029.5840Cover
2018-12-04676,7261,370,99949.3601Short
2018-11-19221,400222,40099.5504Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on TSTS.


About That Marketing Solution, Inc. (OTC: TSTS)

Logo for That Marketing Solution, Inc. (OTC: TSTS)

About That Marketing Solution, Inc TSTS : That Marketing Solution Develops and Markets Health Related Products. The company owns and operates Technology around Micellization Manufacturing Process. This Proprietary Micellization Process converts oil based nutrients into water soluble products for better absorption by the cells. For more information visit www.thatmarketingsolution.com.

 

Contact Information

 

 

Current Management

  • Darren Lopez / CEO
  • Matt Smith / President
    • years experience in Pharmaceutical, BioTech, and Nutritional Sciences Founder and CEO of AMG Inc led manufacturing, marketing and sales for a Swissbased technology in the nutrition and personal care market in US, Europe and Asia over million revenue in years Chief Business Officer of Meyer Pharmaceuticals responsible for strategic business planning and execution and forming several joint ventures and business relationships to facilitate US and Asia markets completed over million in licensing deals and strategic partnerships. Managing Director, LF Technologies, private biotech company established preclinical phase of pharmaceutical development with identified targets and solid IND pathway Early career, worked in sales and marketing for Pfizer and helped launch products in the US including blockbusters Diflucan, Zoloft, and Viagra

Current Share Structure

  • Market Cap: $103,289 - 03/09/2018
  • Authorized: 500,000,000 - 01/09/2015
  • Issue and Outstanding: 516,442,769 - 01/15/2016
  • Float: 26,800,000 - 01/09/2015

 



Daily Technical Chart for (OTC: TSTS)

Daily Technical Chart for (OTC: TSTS)


Stay tuned for daily updates and more on (OTC: TSTS)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: TSTS)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in TSTS is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of TSTS and does not buy, sell, or trade any shares of TSTS. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/